Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 485-492

  Campbell, Douglas H ^a   DeFazio, Anna ^a   Sutherland, Robert L ^a   Daly, Roger J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TYROSINE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOGENE; PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR CELL LINE;

BREAST NEOPLASMS; CORTACTIN; CYCLIN D1; CYCLINS; FEMALE; GENE AMPLIFICATION; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PHOSPHORYLATION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029851750     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<485::AID-IJC14>3.0.CO;2-4     Document Type: Article

References (32)

1. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10, 775-778 (1995).
2. BRINGUIER, P.P., TAMIMI, Y., SCHUURING, E. and SCHALKEN, J., Expression of cyclin D1 and EMSI in bladder tumours; relationship with chromosome11q13 amplification. Oncogene, 12, 1747-1753 (1996).
3. BUCKLEY, M.F., SWEENLY, K.J., HAMILTON, J.A., SlNI, R.L., MANNING, D.L., NICHOLSON, R.I., DEFAZIO, A., WATTS, C.K., MUSGROVE, E.A. and SUTHERLAND, R.L., Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133 (1993).
4. CALAUTTI, E., MISSERO, C., STEIN, P.L., EZZLLL, R.M. and DOTTO, G.P., fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Develop., 9, 2279-2291 (1995).
5. DALY, R.J., SH2 domain-containing signaling proteins in human breast cancer. Breast Cancer Res. Treat., 34, 85-92 (1995).
6. DURIEU-TRAUTMANN, O., CHAVEROT, N., CAZAUBON, S., STROSBERG, A.D. and COURAUD, P.O., Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. biol. Chem., 269, 12536-12540 (1994).
7. FANTL, V., SMITH, R., BROOKKS, S., DICKSON, C. and PETERS, G., Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv., 18, 77-94 (1993).
8. HALL, R.E., LEE, C.S., ALEXANDER, I.E., SHINE, J., CLARKE, C.L. and SUTHERLAND, R.L., Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int. J. Cancer, 46, 1081-1087 (1990).
9. JANES, P.W., DALY, R.J., DEFAZIO, A. and SUTHERLAND, R.L., Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene, 9, 3601-3608 (1994).
10. KARLSEDER, J., ZEILLINGER, R., SCHNEEBERGER, C., CZERWENKA, K., SPEISER, P., KUBISTA, E., BIRNBAUM, D., GAUDRAY, P. and THEILLET, C., Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer, 9, 42-48 (1994).
11. MAA, M.C., WILSON, L.K., MOYERS, J.S., VINES, R.R., PARSONS, J.T. and PARSONS, S.J., Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Oncogene, 7, 2429-2438 (1992).
12. MARUYAMA, S., KUROSAKI, T., SADA, K., YAMANASHI, Y., YAMAMOTO, T. and YAMAMURA, H., Physical and functional association of cortactin with syk in human leukemic cell line K562. J. biol. Chem., 271, 6631-6635 (1996).
13. MIGLARESE, M.R., MANNION-HENDERSON, J., WU, H., PARSONS, J.T. and BENDER, T.P., The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors. Oncogene, 9, 1989-1997 (1994).
14. MISRAHI, M., ATGER, M., D'AURIOL, L., LOOSFELT, H., MERIEL, C., FRIDLANSKY, F., GUIOCHON-MANTEL, A., GALIBERT, F. and MILGROM, E., Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem. biophys. Res. Comm., 143, 740-748 (1987).
15. 1 to complete the cell cycle. Proc. nat. Acad. Sci. (Wash.), 91, 8022-8026 (1994).
16. MUTHUSWAMY, S.K. and MULLER, W.J., Activation of src family kinases in neu-induced mammary tumors correlates with their associa tion with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene, 11, 1801-1810 (1995).
17. MUTHUSWAMY, S.K., SIEGEL, P.M., DANKORT, D.L., WEBSTER, M.A. and MULLER, W.J., Mammary tumors expressing the neu protooncogene possess elevated c-Src tyrosine kinase activity. Mol. cell. Biol., 14, 735-743 (1994).
18. NADA, S., OKADA, M., AIZAWA, S. and NAKAGAWA, H., Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells. Oncogene, 9, 3571-3578 (1994).
19. PATEL, A.M., INCOGNITO, L.S., SCHECHTER, G.L., WASILENKO, W.J. and SOMERS, K.D., Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene, 12, 31-35 (1996).
20. PAWSON, T., Protein modules and signalling networks. Nature (Lond.), 373, 573-580 (1995).
21. PETERS, G., FANTL, V., SMITH, R., BROOKES, S. and DICKSON, C., Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res. Treat., 33, 125-135 (1995).
22. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning - a laboratory manual, 2nd ed., Cold Spring Harhor, NY, Cold Spring Harbor Laboratory Press (1989).
23. SARTOR, O. and ROBBINS, K.C., Substrate specificity for normal but not mutationally activated variants of src family kinases. J. biol. Chem., 268, 21014-21020 (1993).
24. SCHUURING, E., VERHOEVEN, E., LITVINOV, S. and MICHALIDES, R.J.A.M., The product of the EMS1 gene, amplified and overex- pressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol. cell. Biol., 13, 2891-2898 (1993).
25. SCHUURING, E., VERHOEVEN, E., MOOI, W.J. and MICHALIDES, R.J.A.M., Identification and cloning of two overexpressed genes, U21B1\IPRAD1 and EMS 1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene, 7, 355-361 (1992a).
26. SCHUURING, E., VERHOEVEN, E., VAN TINTEREN, H., PETERSE, J.L., NUNNINK, B., THUNNISSEN, F.B., DEVILEE, P., CORNELISSE, C.J., VAN DE VIJVER, M.J., MOOI, W.J. and MICHALIDES, R.J.A.M., Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52, 5229-5234 (19926).
27. THOMAS, S.M., SORIANO, P. and IMAMOTO, A., Specific and redundant roles of src and fyn in organizing the cytoskeleton. Nature (Lond.), 376, 267-271 (1995).
28. WILLIAMS, M.E., GAFFEY, M.J., WEISS, L.M., WILCZYNSKI, S.P., SCHUURING, E. and LEVINE, P.A., Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 119, 1238-1243 (1993).
29. WONG, S., REYNOLDS, A.B. and PAPKOFF, J., Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein. Oncogene, 7, 2407-2415 (1992).
30. Wu, H. and PARSONS, J.T., Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol., 120, 1417-1426 (1993).
31. Wu, H., REYNOLDS, A.B., KANNER, S.B., VINES, R.R. and PARSONS, J.T., Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. cell. Biol., 11, 5113-5124 (1991).
32. ZHAN, X., PLOURDE, C., Hu, X., FRIESEL, R. and MACIAG, T., Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. J. biol. Chem., 269, 20221-20224 (1994).